Service Hotline:
互联网药品信息服务资格证书：（陕）-非经营性-2023-0143
Professional Academic
Professional
Comparison of the Efficacy of CCCHP and CHP in the Treatment of Malignant Effusion
Objective: To compare the efficacy of continuous circulating thermal perfusion chemotherapy (CCCHP) and thermal perfusion chemotherapy (CHP) in body cavities.
2025-02-11
Objective: To explore the efficacy of continuous circulating hyperthermic intraperitoneal chemotherapy at a constant temperature (42~43°C) for malignant ascites.
2025-02-11
Objective: To compare and analyze the effects of intraperitoneal hyperthermic perfusion chemotherapy and intraperitoneal perfusion chemotherapy in the treatment of colorectal cancer.
2025-02-11
Objective: To evaluate the efficacy and safety of chemotherapy combined with intraperitoneal hyperthermic perfusion in the treatment of malignant tumors with ascites.
2025-02-11
Objective: To observe the efficacy of intraperitoneal circulation hyperthermic perfusion chemotherapy in the treatment of malignant ascites.
2025-02-11
The National Cancer Center has just released: 2024 National Cancer Report
Recently, approved by the National Health Commission, the National Cancer Center released the 2022 burden of malignant tumors in China based on the latest data from tumor registration and follow-up monitoring on JNCC.
2025-02-11
In the past two years, the use of constant temperature circulating thermal perfusion for intraperitoneal and venous double-route hyperthermic chemotherapy has achieved satisfactory results in preventing and treating intraperitoneal metastatic cancer, which cannot be achieved by non-circulating thermal perfusion chemotherapy.
2025-02-11
Objective: To explore the nursing methods for treating malignant ascites with normothermic hyperthermic perfusion chemotherapy during extracorporeal circulation.
2025-02-11
Clinical observation of hot infusion chemotherapy for malignant pleural effusion
Objective: To observe the clinical effects and adverse reactions of extracorporeal high-frequency hyperthermia combined with intrathoracic thermal perfusion chemotherapy in the treatment of malignant pleural effusion.
2025-02-11
Objective: To evaluate the clinical efficacy, quality of life, and toxic side effects of oral S-1 combined with intraperitoneal hyperthermic chemotherapy in the treatment of advanced gastric cancer with ascites.
2025-02-11
Mobile
-
TEL： +86 29 82681864
Fax：+86 29 82681864 E-mail：gd029@126.comAdd: Building 1, Huoju Road, East zone of Xi’an High-tech Development District, Xi'an, China
互联网药品信息服务资格证书（陕）-非经营性-2023-0143